Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40085

DUSP5 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DUSP5 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited knockout population of HEK293T cells designed to disrupt the DUSP5 dual-specificity phosphatase. This model removes negative feedback regulation of ERK1/2, yielding hyperactive MAPK signaling, and is ideal for studying oncogenic pathway activation and feedback mechanisms. HEK293T cells, expressing SV40 large T antigen, provide high transfection efficiency and active signaling networks. The knockout cells facilitate analysis of DUSP5-dependent ERK phosphorylation, ELK1, and c-Fos expression, and are suited for cancer signaling research, drug target validation, and functional reporter assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DUSP5

    Gene Identifier

    NCBI Gene ID 1847

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DUSP5 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population of human embryonic kidney cells in which the DUSP5 gene has been disrupted. This loss-of-function model enables detailed investigation of the negative regulation of the MAPK/ERK signaling cascade in a well-characterized and widely used cell background. The polyclonal nature captures a heterogeneous spectrum of gene edits, making it particularly suitable for studying population-level signaling responses without the confounding influence of single-cell clonal selection.

The host HEK293T cell line is derived from human embryonic kidney cells transformed with adenovirus 5 DNA and stably expresses the SV40 large T antigen. This genetic modification permits episomal replication of plasmids containing the SV40 origin of replication and supports high-level transient transgene expression. HEK293T cells are extensively employed in biomedical research for recombinant protein production, lentiviral and retroviral packaging, and functional promoter assays, owing to their robust growth, high transfection efficiency, and active intracellular signaling networks.

DUSP5 encodes a nuclear dual-specificity phosphatase that binds activated ERK1/2 via its kinase-interaction motif (KIM) domain and dephosphorylates the regulatory residues, attenuating MAPK pathway output. It acts as a negative feedback regulator, transcriptionally induced by ERK-dependent ELK1 and SRF downstream of receptor tyrosine kinases. In the Ras?CRaf?CMEK1/2?CERK1/2 cascade, DUSP5 opposes ERK1/2 phosphorylation, reducing activity of transcription factors such as ELK1, c-Fos, and c-Jun. Disruption of DUSP5 removes this feedback brake, yielding sustained ERK activation and heightened immediate-early gene expression.

In the HEK293T context, ablation of DUSP5 creates a hyperactive ERK signaling environment that partially mimics oncogenic pathway activation. This model enables researchers to dissect the specific contribution of DUSP5 to ERK signal duration, amplitude, and transcriptional output under defined stimulation conditions. Because HEK293T cells already possess active basal signaling and are highly permissive to transient and stable genetic manipulation, the knockout background is particularly advantageous for examining how DUSP5 shapes proliferative and survival signals. The polyclonal composition avoids clonal variation in knockout penetrance and phenotypic drift, providing a more representative view of signaling heterogeneity within the cell population.

This DUSP5 knockout model is suited for a broad range of applications, including MAPK pathway functional analysis, cancer cell signaling studies, drug target validation, and investigation of feedback regulatory mechanisms. Representative downstream assays include Western blotting for phosphorylated ERK1/2, RT-qPCR quantification of DUSP5 and ERK transcriptional targets, immunofluorescence localization of active ERK, and serum response element (SRE)-luciferase reporter assays. High-content screening campaigns can also leverage these cells to identify small-molecule modulators of ERK signaling. For further technical information or to discuss custom genome-editing services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)